Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRAB: Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer
NCT00842686Phase 2Unknown
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Jan 2009
- Primary completion
- Aug 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rectal cancer, sponsored by Institute of Oncology Ljubljana. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00842686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842686.